PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 178 results · Respiratory  · Clear
🔒 Subscribers only
AUTH/3699/10/22
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca v GSK
AstraZeneca complained about GSK’s UK HCP promotional webpage and embedded video on the Trelegy (FF/UMEC/VI) GSKpro site, which presented results from a published Network Meta-analysis (NMA) in C…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3715/11/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
An anonymous, contactable complainant challenged a video on GSK’s UK respiratory promotional website (Trelegy Ellipta site) summarising a GSK ERS 2022 symposium. The video presented results from …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3719/12/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
Chiesi complained about GSK promotional materials for Trelegy (website pages, an embedded video and an ERS 2022 leavepiece).Four issues were escalated: (1) a rotating banner ad showing competitor i…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3621/3/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi breached the ABPI Code after a third-party event email implied sponsorship of a prize draw tied to attending
A health professional complained about a reminder email for a MIMS Live Digital Event (21–23 March 2022) offering a chance to win a free annual subscription to MIMS Learning.To enter the draw, de…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3641/4/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached ABPI Code over DuoResp Spiromax website
An anonymous, contactable complainant (a health professional) raised concerns about the DuoResp Spiromax (budesonide/formoterol) website, particularly when viewed on a mobile device.The complaint a…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3664/6/22
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable health professional complained about a promotional email for Symbicort Turbohaler (budesonide, formoterol fumarate).The email subject line was: ‘AstraZeneca promotional …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3638/4/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis breached ABPI Code over ‘Think Symptom-free’ claim for Xolair on HCP website (AUTH/3638/4/2
A healthcare professional complained about promotional messaging for Xolair (omalizumab) on Novartis’ UK HCP website (health.novartis.co.uk), covering pages for Chronic Spontaneous Urticaria (CSU…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3678/8/22
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached Code over Symbicort MART messaging and missing PI reference in
An anonymous, contactable health professional complained about a Symbicort (budesonide/formoterol) hard-copy advertisement in the June 2022 edition of MIMS (ref GB-35766, April 2022), appearing on …
Clauses: 4.1,4.3
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3645/5/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Proveca
A health professional complainant raised multiple concerns about the Sialanar (glycopyrronium bromide) dosing calculator app hosted at sialanar-website.firebaseapp.com, accessible via a promotional…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3470/2/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable complainant (self-described health professional) complained about a four-frame digital banner advertisement for Seretide Evohaler (fluticasone/salmeterol) (ref PM-GB-FPS-W…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3522/6/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A health professional complained about promotion of Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) by GlaxoSmithKline UK Limited.Materials complained about:BTS Winter Meeting (Feb 2021) supp…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3488/3/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached Code over Trixeo website mobile display and missing comparator prescribing info
An anonymous complainant challenged AstraZeneca’s UK promotional website for Trixeo Aerosphere (www.trixeo.co.uk) and a downloadable Trixeo formulary pack.Allegations included: public access (no …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3477/2/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca Symbicort Turbu+ package deal
An anonymous, non-contactable complainant (described as a respiratory nurse) complained about AstraZeneca UK’s Symbicort Turbohaler (budesonide/formoterol) “Turbu+” package deal and the Turbu…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3515/5/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK webinar registration implied COPD medicines were licensed for asthma; Clause 2 upheld on appeal
An anonymous health professional complained about two items promoting Seretide (fluticasone/salmeterol) by GlaxoSmithKline UK Limited (GSK).Item A (webinar registration page): An online registratio…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3451/1/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva respiratory websites
An anonymous (initially contactable) health professional complained about two Teva-owned sites: the Teva UK corporate site (HCP respiratory section) and the “Let’s Talk Respiratory” (LTR) web…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3516/5/21
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi webinar
A health professional complained about a Chiesi-organised webinar (25 May 2021) titled “Session 3: Evolving Developments in the Management of asthma”.Concerns included: prescribing information …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3557/9/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, non-contactable complainant (pharmacist in a primary care network) challenged GSK’s promotion of Seretide Evohaler (salmeterol/fluticasone propionate).The complaint focused on a GSK…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3587/12/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous complainant (self-described health professional) complained about a Symbicort (budesonide formoterol fumarate dihydrate) cost-calculator webpage on medicines.astrazeneca.co.uk.The comp…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3573/10/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK corporate website
An anonymous, contactable complainant (health professional) alleged GSK’s Global UK corporate website promoted its product pipeline to UK health professionals.The complainant also alleged an inve…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3585/11/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached the Code over incomplete Symbicort dosing and missing prescribing information/n
An anonymous, contactable health professional complained about AstraZeneca respiratory promotional content across multiple webpages and a digital ad (Code year 2021). Symbicort webpage (GB-31536, O…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3482/3/21
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A complaint was made alleging promotion of Nucala (mepolizumab) on LinkedIn.The matter was assessed by the PMCPA as outwith the scope of the ABPI Code of Practice.
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3384/9/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Bayer ‘Dear Pharmacist’ Ventavis letter found via Google indexing
A UK health professional complained about a 2012 “Dear Pharmacist” letter on Bayer’s UK website regarding distribution/supply of Ventavis (iloprost trometamol).The complainant alleged the mat…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3402/10/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Sanofi
A health professional complained that material on Sanofi’s Dupixent (dupilumab) product website (dupixent.co.uk) was inaccurate.Two downloadable resources were highlighted:A document referring to…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3414/11/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable complainant challenged a Novartis Pharmaceuticals UK Ltd corporate webpage (“Our work in Respiratory and Inflammation”) that included a table of three “pipeline” p…
Clauses: NONE
2020 🔒 Subscribe
← Prev 1 2 3 4 5 Next → Page 2 of 8 — 178 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews